These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8312329)

  • 1. Strategies for prolonged survival before heart transplantation in the neonatal intensive care unit.
    Emery JR
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S161-3. PubMed ID: 8312329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
    J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interventional cardiology in pediatric heart transplantation.
    Ruiz CE; Zhang HP; Larsen RL
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S164-7. PubMed ID: 8312330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing care of the neonate receiving prostaglandin E1 therapy.
    Rikard DH
    Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation].
    Caballero S; Torre I; Arias B; Blanco D; Zabala JI; Sánchez Luna M
    An Esp Pediatr; 1998 May; 48(5):505-9. PubMed ID: 9656538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
    Iberer F; Wasler A; Tscheliessnigg K; Petutschnigg B; Auer T; Müller H; Rödl S
    J Heart Lung Transplant; 1993; 12(2):173-8. PubMed ID: 8476887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care of infants with hypoplastic left heart syndrome.
    Smith JB; Vernon-Levett P
    AACN Clin Issues Crit Care Nurs; 1993 May; 4(2):329-39. PubMed ID: 8489880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease.
    Collins MH; Darragh RK; Caldwell RL; Turrentine MW; Brown JW
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1116-25. PubMed ID: 8719459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease.
    Friedman AH; Fahey JT
    Semin Perinatol; 1993 Apr; 17(2):106-21. PubMed ID: 8327901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. The Loma Linda University Pediatric Heart Transplant Group.
    Bailey LL; Gundry SR; Razzouk AJ; Wang N; Sciolaro CM; Chiavarelli M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):805-14; discussion 814-5. PubMed ID: 8487560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined prostaglandin therapy and ductal formalin infiltration in neonatal pulmonary oligemia.
    Larson JE; Fleming WH; Sarafian LB; Rogler WC; Hofschire PJ; McManus BM
    J Thorac Cardiovasc Surg; 1985 Dec; 90(6):907-11. PubMed ID: 4068741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
    Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
    Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-based interventional palliation for hypoplastic left heart syndrome.
    Boucek MM; Mashburn C; Chan KC
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2005; ():72-7. PubMed ID: 15818361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplantation management of the newborn and the immunosuppressive role of prostaglandin E1.
    Assaad A
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S191-4. PubMed ID: 8312335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
    Fernández MA; Gebara E
    Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
    Heymann MA; Rudolph AM
    Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
    Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
    J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
    Noah ML
    Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.